Highest development stage: Phase 3

Development status: Active

Gram-negative activity

Mechanism of Action/Target pathogen: Health care-associated pneumonia, bloodstream infections, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated urinary tract infections